What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Cardiology
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Troponin and Heart failure.
Internal medicine connects with themes related to Endocrinology in his study.
His Cardiology research is multidisciplinary, incorporating perspectives in Predictive value of tests and Hazard ratio.
His Myocardial infarction study integrates concerns from other disciplines, such as Medical laboratory and Pathology.
His study in Troponin is interdisciplinary in nature, drawing from both Surgery, Chest pain and Infarction.
Robert H. Christenson interconnects Intensive care medicine, Proportional hazards model, Biomarker, Prospective cohort study and Risk factor in the investigation of issues within Heart failure.
His most cited work include:
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia (1021 citations)
- Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute (662 citations)
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease (637 citations)
What are the main themes of his work throughout his whole career to date?
Robert H. Christenson focuses on Internal medicine, Cardiology, Myocardial infarction, Heart failure and Troponin.
His Internal medicine study frequently draws connections to adjacent fields such as Endocrinology.
In his research, Predictive value of tests is intimately related to Prospective cohort study, which falls under the overarching field of Cardiology.
His biological study spans a wide range of topics, including Biomarker, Surgery and Creatine kinase.
His work carried out in the field of Heart failure brings together such families of science as Hazard ratio, Medical laboratory, Heart disease and Intensive care medicine.
The Intensive care medicine study combines topics in areas such as Clinical biochemistry and MEDLINE.
He most often published in these fields:
- Internal medicine (68.16%)
- Cardiology (48.44%)
- Myocardial infarction (27.54%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (68.16%)
- Cardiology (48.44%)
- Myocardial infarction (27.54%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Cardiac troponin and Emergency department.
Internal medicine is frequently linked to Gastroenterology in his study.
Robert H. Christenson has researched Cardiology in several fields, including Prospective cohort study and Kidney disease.
While the research belongs to areas of Myocardial infarction, Robert H. Christenson spends his time largely on the problem of Coronary artery disease, intersecting his research to questions surrounding Ischemia.
His Cardiac troponin research is multidisciplinary, incorporating elements of Troponin I and Cohort.
Robert H. Christenson works mostly in the field of Heart failure, limiting it down to topics relating to Subclinical infection and, in certain cases, Body mass index, as a part of the same area of interest.
Between 2017 and 2021, his most popular works were:
- Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. (184 citations)
- Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. (111 citations)
- N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study (51 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Robert H. Christenson spends much of his time researching Internal medicine, Cardiology, Cardiac troponin, Myocardial infarction and Biomarker.
In most of his Internal medicine studies, his work intersects topics such as Gastroenterology.
His Cardiology research integrates issues from Prospective cohort study, Peritoneal dialysis and Hemodialysis.
He has included themes like Troponin, Clinical biochemistry, Troponin I and Acute coronary syndrome in his Cardiac troponin study.
His work deals with themes such as Presentation, Copeptin and Adverse effect, which intersect with Myocardial infarction.
His Biomarker research incorporates elements of Glasgow Coma Scale, Predictive value and Observational Trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
